Apollo Hospitals Partners with Roche Diagnostics to Pioneer AI-Driven Clinical Care

Apollo Hospitals has signed a Memorandum of Understanding (MoU) with Roche Diagnostics India to integrate artificial intelligence into clinical decision-making. It was formalized at THIT 2026 (the annual Transforming Healthcare with IT event organised by Apollo Hospitals) in the presence of Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals Group and Mr. Rishubh Gupta, Managing Director, Roche Diagnostics India & Neighbouring Markets.
 

At the core of this partnership is Roche's Navify Algorithm Suite — a sophisticated, cloud-based clinical decision support platform. It integrates with Apollo's clinical systems to deliver tailored patient insights, enable earlier detection of complex diseases, and enhance workflow efficiency by connecting electronic medical records (EMR), laboratory information systems (LIS), and hospital information systems (HIS).
 

By merging Apollo's clinical expertise with Roche's digital tools, the initiative supports real-world AI validation at Apollo's research centres, ensuring reliable performance across diverse settings.
 

Dr. Sangita Reddy emphasized the focus on digital transformation: "We aim to accelerate early diagnosis, streamline workflows, and enhance quality of life for patients." Mr. Rishubh Gupta highlighted transforming data into actionable intelligence for scalable, precise decisions.
 

This alliance underscores Apollo's commitment to evidence-based innovation, benefiting millions through its network of over 74 hospitals, 6,600+ pharmacies, 264 clinics, 2,182 diagnostic centres, and 800+ telemedicine centres. Patients gain from faster, more accurate care, while clinicians benefit from efficient tools — advancing a patient-first healthcare ecosystem.